Skip to main content
SpringerLink
Log in

Serious AEs uncommon after second mRNA COVID-19 booster

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Hause AM, et al. Safety Monitoring of COVID-19 mRNA Vaccine Second Booster Doses Among Adults Aged ?50 Years ? United States, March 29, 2022?July 10, 2022 Morbidity and Mortality Weekly Report : 5 Aug 2022. Available from: URL: https://doi.org/10.15585/mmwr.mm7130a4

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Serious AEs uncommon after second mRNA COVID-19 booster. Reactions Weekly 1919, 11 (2022). https://doi.org/10.1007/s40278-022-20953-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-022-20953-z

Search

Navigation